REG - TempletonEmerg.Mkt. - Board Appointment

Templeton Emerging Markets Investment TrustAnnouncement

05/06/2018 18:10

RNS Number : 4117Q
Templeton Emerging Markets IT PLC
05 June 2018
 


5 June 2018
 
Stock Exchange Announcement
Templeton Emerging Markets Investment Trust PLC ("the Company")
Board Appointment
Legal Entity Identifier 5493002NMTB70RZBXO96
 
Templeton Emerging Markets Investment Trust PLC ("TEMIT" or the "Company") announces that the Board of Directors are proposing to appoint Charlie Ricketts as a non-executive Director of the Company, with effect from 12 July 2018, if approved by Shareholders at the Company's AGM which is due to be held on 12 July 2018.
 
The Chairman, Paul Manduca said "With over 30 years' experience in the investment trust sector, Charlie Ricketts brings a wealth of experience to the Board. He was Head of Investment Funds at Cenkos Securities for 8 years and prior to that was Managing Director, Head of Investment Companies at UBS Investment Bank. Since stepping down from Cenkos in 2014 he has pursued a number of business and charitable interests."
 
The Company discloses this information pursuant to Listing Rule 9.6.11.R and 9.6.13 R made by the UK Listing Authority. This disclosure is based upon information provided by such Director and has not been independently verified by the Company.
 
Mr. Ricketts has no details to disclose pursuant to Listing Rule 9.6.13 R (2) to Listing Rule 9.6.13 R (6).
 
Mr Ricketts is a non-executive director of Edinburgh Dragon Trust plc.
 
 
For further information:
 



Franklin Templeton Investments - Stephen Westwood


07533 178381




Templeton Emerging Markets Investment Trust PLC - Sara MacIntosh


0131 242 4165




Winterflood Investment Trusts, Corporate Broker - Neil Langford


0203 100 0000























 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABRGDLDGGBGIU